Search
for
Sort by
Research 391–420 of 1000+
- Age-dependent endocrine disorders involved in the pathogenesis of refractory acne in women
- The Evaluation and Management of Hirsutism
- Minoxidil and male-pattern alopecia: a potential role for a local regulator of sebum secretion with vasoconstrictive effects?
- Efficacy and Safety of Tracnil™ Administration in Patients with Dermatological Manifestations of PCOS: An Open-Label Single-Arm Study
- Cost-effective therapy in patients with idiopathic hirsutism
- Systemic retinoids and thyrotoxicosis in (Multi) nodular goiter: Side effect or coincidence?
- Chirurgie des schwannomes vestibulaires solitaires
- Novel anti-Mullerian hormone receptor 2 binding peptide prevents chemotherapy-related ovarian follicle loss in a mouse model
- Managing Acne in Individuals with Polycystic Ovarian Syndrome
- Short-Term Clinical Assessment of Treating Female Androgenic Alopecia with Autologous Stem Cells Derived from Human Hair Follicles
- Management of Hirsutism Associated With Obese PCOD - A Case Report
- 410 NON-INVASIVE DIAGNOSIS OF PROSTATE CANCER FROM BODY FLUIDS USING A PANEL OF TUMOR SUPPRESSOR GENES
- Reporting on Adverse Clinical Events
- Mouse models with a disrupted PTHrP gene or a disrupted PTH gene (PTH−/− mice)
- Feline Symmetrical Alopecia
- Facial Pores
- Female Pattern Hair Loss
- Severe Hirsutism in Non Classic Congenital Adrenal Hyperplasia: A Case Report and Literature Review
- Haarverlies volgens het vrouwelijk patroon:Een folder voor uw patiënten
- Androgenetic alopecia in males – characteristics and overview of therapies available in cosmetology and aesthetic medicine clinics
- Female pattern hair loss (a review)
- Estrogens and the skin
- Hormonal Treatment of Transgender Women with Oral Estradiol
- Incidence of alopecia from endocrine therapies in cancer
- Gonads
- Molecular Genetic and Endocrine Mechanisms of Hair Growth
- Vitamin D-dependent rickets type II: extreme end organ resistance to 1,25-dihydroxy vitamin D3 in a patient without alopecia
- Effects of two estroprogestins containing ethynilestradiol 30mug and drospirenone 3 mg and ethynilestradiol 30mug and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations
- Female pattern hair loss
- DERMATOLOGIC DISEASES AND PROBLEMS OF WOMEN THROUGHOUT THE LIFE CYCLE